| 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 50,2 k € | +176.8% | 18,2 k € | +121.1% | -86,0 k € | +23.9% | -113,0 k € | -24.5% | -90,7 k € | |
| EBITDA | 49,4 k € | +179.7% | 17,7 k € | +120.5% | -86,3 k € | +23.8% | -113,3 k € | -24.9% | -90,7 k € | |
| Operating profit | 49,4 k € | +179.7% | 17,7 k € | +120.5% | -86,3 k € | +23.8% | -113,3 k € | -24.9% | -90,7 k € | |
| Profit/loss | 38,9 k € | +1346.6% | 2,7 k € | +102.6% | -102,2 k € | +13.3% | -117,9 k € | -29.2% | -91,3 k € | |
| Equity | -269,7 k € | +12.6% | -308,5 k € | +0.9% | -311,2 k € | -48.9% | -209,0 k € | -129.3% | -91,2 k € | |
| Total assets | 1,1 M € | +68.6% | 635,4 k € | +163.4% | 241,2 k € | -20.0% | 301,4 k € | +301317.4% | 100,0 € | |
| Cash | 49,1 k € | -89.9% | 484,2 k € | +104.9% | 236,4 k € | -18.1% | 288,5 k € | — | ||
| Debts | 1,3 M € | +42.1% | 944,0 k € | +70.9% | 552,5 k € | +8.2% | 510,5 k € | +459.4% | 91,3 k € | |
Private limited company · Zaventem · incorporated on 22/02/2021
Private limited company with a balanced profile. Cash position declining (-89.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
IQVIA Cancer Research is a Private limited company incorporated in 2021. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Zaventem.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette